Lynparza 100 mg film-coated tablets, ABIRATERONE , PREDNISOLONE , Lynparza 150 mg film-coated tablets
PROpel D081SC00001
Phase 3 small_molecule active
Quick answer
Lynparza 100 mg film-coated tablets, ABIRATERONE , PREDNISOLONE , Lynparza 150 mg film-coated tablets for Metastatic castration-resistant prostate cancer is a Phase 3 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Metastatic castration-resistant prostate cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active